Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 21

Trial Status

Completed1

Role Distribution

Principal Investigator1
PI Rate100%

Activity Timeline

Clinical Trials (1)

NCT02363283Phase 2Completed
Glembatumumab Vedotin in Treating Patients With Metastatic or Locally Recurrent Uveal Melanoma
Recurrent Uveal MelanomaStage IV Uveal Melanoma AJCC v7
PrincipalinvestigatorStart date: 2015-09-16

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

University of Texas MD Anderson Cancer Center LAO

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Alexander N Shoushtari

Memorial Sloan Kettering Cancer Center

Moderately Similar
2 trials

Shared therapeutic areas:

Stage IV Uveal Melanoma AJCC v7Recurrent Uveal Melanoma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score30%

David H Lawson

Eastern Cooperative Oncology Group

Moderately Similar
1 trials

Shared therapeutic areas:

Recurrent Uveal MelanomaStage IV Uveal Melanoma AJCC v7

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score30%

Jason J Luke

Alliance for Clinical Trials in Oncology

Moderately Similar
2 trials

Shared therapeutic areas:

Recurrent Uveal MelanomaStage IV Uveal Melanoma AJCC v7

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score30%

Craig Slingluff

Cancer Immunotherapy Trials Network

Related
1 trials

Shared therapeutic areas:

Recurrent Uveal Melanoma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score15%

Paul Chapman

Memorial Sloan Kettering Cancer Center

Related
3 trials

Shared therapeutic areas:

Recurrent Uveal Melanoma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score15%

Sapna Patel

M.D. Anderson Cancer Center

Related
2 trials

Shared therapeutic areas:

Stage IV Uveal Melanoma AJCC v7

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score15%

Svetomir N Markovic

Academic and Community Cancer Research United

Related
1 trials

Shared therapeutic areas:

Stage IV Uveal Melanoma AJCC v7

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score15%

Haeseong Park

Duke University - Duke Cancer Institute LAO

Related
1 trials

Shared therapeutic areas:

Stage IV Uveal Melanoma AJCC v7

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score15%

Rodabe N Amaria

M.D. Anderson Cancer Center

Related
6 trials

Shared therapeutic areas:

Stage IV Uveal Melanoma AJCC v7

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score15%

Marlana Orloff, MD

Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University

Related
1 trials

Shared therapeutic areas:

Stage IV Uveal Melanoma AJCC v7
Similarity Score15%

Publications (0)

No publications found for this investigator.

Clinical Trials (1)

Showing 1 of 1 trials

NCT02363283Phase 2PrincipalInvestigator

Glembatumumab Vedotin in Treating Patients With Metastatic or Locally Recurrent Uveal Melanoma

Recurrent Uveal MelanomaStage IV Uveal Melanoma AJCC v7
Completed

All 1 trials loaded